ADAR1p150 Forms a Complex with Dicer to Promote MiRNA-222 Activity and Regulate PTEN Expression in CVB3-Induced Viral Myocarditis

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2019 Jan 24

PMID 30669342

Citations 20

Authors

Xincai Zhang

Xiangting Gao

Jun Hu

Yuxin Xie

Yuanyi Zuo

Hongfei Xu

Shaohua Zhu

Affiliations

Soon will be listed here.

Abstract

Adenosine deaminases acting on RNA (ADAR) are enzymes that regulate RNA metabolism through post-transcriptional mechanisms. ADAR1 is involved in a variety of pathological conditions including inflammation, cancer, and the host defense against viral infections. However, the role of ADAR1p150 in vascular disease remains unclear. In this study, we examined the expression of ADAR1p150 and its role in viral myocarditis (VMC) in a mouse model. VMC mouse cardiomyocytes showed significantly higher expression of ADAR1p150 compared to the control samples. Coimmunoprecipitation verified that ADAR1p150 forms a complex with Dicer in VMC. miRNA-222, which is involved in many cardiac diseases, is highly expressed in cardiomyocytes in VMC. In addition, the expression of miRNA-222 was promoted by ADAR1p150/Dicer. Among the target genes of miRNA-222, the expression of phosphatase-and-tensin (PTEN) protein was significantly reduced in VMC. By using a bioinformatics tool, we found a potential binding site of miRNA-222 on the PTEN gene's 3'-UTR, suggesting that miRNA-222 might play a regulatory role. In cultured cells, miR-222 suppressed PTEN expression. Our findings suggest that ADAR1p150 plays a key role in complexing with Dicer and promoting the expression of miRNA-222, the latter of which suppresses the expression of the target gene PTEN during VMC. Our work reveals a previously unknown role of ADAR1p150 in gene expression in VMC.

Citing Articles

Role of non-coding RNAs in the pathogenesis of viral myocarditis.

Kang Z, Zhang L, Yang Z Virulence. 2025; 16(1):2466480.

PMID: 39950847 PMC: 11849450. DOI: 10.1080/21505594.2025.2466480.

A novel microRNA promotes coxsackievirus B4 infection of pancreatic β cells.

Lalani S, Knudsen J, Kenney J, Hober D, DiPersio C, Gerber A Front Immunol. 2024; 15:1414894.

PMID: 39697323 PMC: 11652211. DOI: 10.3389/fimmu.2024.1414894.

RNA binding proteins in cardiovascular development and disease.

Verma S, Kuyumcu-Martinez M Curr Top Dev Biol. 2024; 156:51-119.

PMID: 38556427 PMC: 11896630. DOI: 10.1016/bs.ctdb.2024.01.007.

MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.

Rani P, George B, V S, Biswas S, V M, Pal A J Virol. 2024; 98(2):e0150423.

PMID: 38289119 PMC: 10883805. DOI: 10.1128/jvi.01504-23.

Superfamily II helicases: the potential therapeutic target for cardiovascular diseases.

Fang T, Wang X, Huangfu N Front Cardiovasc Med. 2023; 10:1309491.

PMID: 38152606 PMC: 10752008. DOI: 10.3389/fcvm.2023.1309491.

References

Rueter S, Dawson T, Emeson R . Regulation of alternative splicing by RNA editing. Nature. 1999; 399(6731):75-80. DOI: 10.1038/19992. View

Rabinovici R, Kabir K, Chen M, Su Y, Zhang D, Luo X . ADAR1 is involved in the development of microvascular lung injury. Circ Res. 2001; 88(10):1066-71. DOI: 10.1161/hh1001.090877. View

Bendig J, OBRIEN P, Muir P, Porter H, Caul E . Enterovirus sequences resembling coxsackievirus A2 detected in stool and spleen from a girl with fatal myocarditis. J Med Virol. 2001; 64(4):482-6. DOI: 10.1002/jmv.1075. View

Van de Sande T, De Schrijver E, Heyns W, Verhoeven G, Swinnen J . Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res. 2002; 62(3):642-6. View

Huang J, Kontos C . Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN. Arterioscler Thromb Vasc Biol. 2002; 22(5):745-51. DOI: 10.1161/01.atv.0000016358.05294.8d. View

Yang J, Luo X, Nie Y, Su Y, Zhao Q, Kabir K . Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation. Immunology. 2003; 109(1):15-23. PMC: 1782949. DOI: 10.1046/j.1365-2567.2003.01598.x. View

Yuan J, Zhao W, Wang H, Wu K, Li T, Guo X . Coxsackievirus B3-induced apoptosis and caspase-3. Cell Res. 2003; 13(3):203-9. DOI: 10.1038/sj.cr.7290165. View

Hoopengardner B, Bhalla T, Staber C, Reenan R . Nervous system targets of RNA editing identified by comparative genomics. Science. 2003; 301(5634):832-6. DOI: 10.1126/science.1086763. View

Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G . Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A. 1992; 89(1):314-8. PMC: 48227. DOI: 10.1073/pnas.89.1.314. View

10.

Chow L, Beisel K, McManus B . Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest. 1992; 66(1):24-31. View

11.

Griffiths-Jones S . The microRNA Registry. Nucleic Acids Res. 2003; 32(Database issue):D109-11. PMC: 308757. DOI: 10.1093/nar/gkh023. View

12.

Keegan L, Leroy A, Sproul D, OConnell M . Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes. Genome Biol. 2004; 5(2):209. PMC: 395743. DOI: 10.1186/gb-2004-5-2-209. View

13.

Moon S, Kim H, Kim C . PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-kappaB and AP-1 in vascular smooth muscle cells. Arch Biochem Biophys. 2004; 421(2):267-76. DOI: 10.1016/j.abb.2003.11.007. View

14.

Oudit G, Sun H, Kerfant B, A Crackower M, Penninger J, Backx P . The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol. 2004; 37(2):449-71. DOI: 10.1016/j.yjmcc.2004.05.015. View

15.

Carniel E, Sinagra G, Bussani R, Lenarda A, Pinamonti B, Lardieri G . Fatal myocarditis: morphologic and clinical features. Ital Heart J. 2004; 5(9):702-6. View

16.

Tam P . Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol. 2006; 19(2):133-46. DOI: 10.1089/vim.2006.19.133. View

17.

Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou A, Nishikura K . Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science. 2007; 315(5815):1137-40. PMC: 2953418. DOI: 10.1126/science.1138050. View

18.

Gandy S, Linnstaedt S, Muralidhar S, Cashman K, Rosenthal L, Casey J . RNA editing of the human herpesvirus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication. J Virol. 2007; 81(24):13544-51. PMC: 2168827. DOI: 10.1128/JVI.01521-07. View

19.

Tamguney T, Stokoe D . New insights into PTEN. J Cell Sci. 2007; 120(Pt 23):4071-9. DOI: 10.1242/jcs.015230. View

20.

Esfandiarei M, McManus B . Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol. 2007; 3:127-55. DOI: 10.1146/annurev.pathmechdis.3.121806.151534. View